T CELL MEMORY TO RESPIRATORY VIRUSES
呼吸道病毒的 T 细胞记忆
基本信息
- 批准号:2672550
- 负责人:
- 金额:$ 16.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-04-01 至 2001-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Respiratory virus infections ar a major problem for the aged, the very
young, and a common complicating factor in immunocompromised transplant or
cancer patients. In this context, the practical challenges are to develop
better vaccines and enhanced mechanisms for maintaining and manipulating
the cell populations that comprise immunological memory. The obverse of
this problem is the desire to subvert the consequences of prior antigen
priming in, for example, the use of virus-vector systems for gene therapy
of cystic fibrosis. An underlying difficulty for both sets of approaches
is that immunological memory is, in general, poorly understood. The
experimental dissection of memory is technically demanding, rigorous
analytical approaches have often been lacking, and there is substantial
controversy and confusion. Many of the studies with non-viral systems are
of limited value, as the experiments have been done with phenotypically-
marked lymphocyte populations of unknown antigen specificity. Considerable
effort has thus been made to develop mouse models for the quantitative,
functional analysis of T cell memory to a parainfluenza type 1 virus
(Sendai) and to the influenza A viruses. The intention is to use these
experimental systems for the further clarification of the establishment,
maintenance and recall phase of virus-specific CD4+ and CD8+ T cell memory.
Attention will be given to the relative significance of events driven via
the clonotypic T cell receptor for antigen, and the possible consequences
of both intercurrent infections and more physiologically-mediated processes
associated with the maintenance of homeostasis in the total pool of T
lymphocytes. The experiments will inevitably lead to better understanding
of the nature of T cell memory, and help provide novel insights for both
vaccine development and possible therapy.
呼吸道病毒感染是老年人的一个主要问题
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER C DOHERTY其他文献
PETER C DOHERTY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER C DOHERTY', 18)}}的其他基金
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A Viruses
针对致命性 H5N1 甲型流感病毒的保护性细胞介导的免疫
- 批准号:
7426908 - 财政年份:2006
- 资助金额:
$ 16.9万 - 项目类别:
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A Viruses
针对致命性 H5N1 甲型流感病毒的保护性细胞介导的免疫
- 批准号:
7129242 - 财政年份:2006
- 资助金额:
$ 16.9万 - 项目类别:
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A Viruses
针对致命性 H5N1 甲型流感病毒的保护性细胞介导的免疫
- 批准号:
7849033 - 财政年份:2006
- 资助金额:
$ 16.9万 - 项目类别:
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A Viruses
针对致命性 H5N1 甲型流感病毒的保护性细胞介导的免疫
- 批准号:
7232680 - 财政年份:2006
- 资助金额:
$ 16.9万 - 项目类别:
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A Viruses
针对致命性 H5N1 甲型流感病毒的保护性细胞介导的免疫
- 批准号:
7622169 - 财政年份:2006
- 资助金额:
$ 16.9万 - 项目类别:
SINGLE CELL ANALYSIS OF A MULTI-TIER AIDS VACCINE
多层艾滋病疫苗的单细胞分析
- 批准号:
6320775 - 财政年份:2000
- 资助金额:
$ 16.9万 - 项目类别:
SINGLE CELL ANALYSIS OF A MULTI-TIER AIDS VACCINE
多层艾滋病疫苗的单细胞分析
- 批准号:
6167468 - 财政年份:1999
- 资助金额:
$ 16.9万 - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 16.9万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 16.9万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别: